Report Categories
View AllRecent Articles
View All
The long term thesis for Aimei Health AFJK in plain sight Froths 20260511
Newmont Corp NEM PreEarnings Analysis Can the Gold Mining Leader Extend Its 5Quarter Beat Streak Amid Volatile Commodity Markets
News Analysis How a mother of Elon Musks children became a key witness in his lawsuit against
How Interparfums IPAR stacks up against analyst expectations 304 20260511
US Bancorp USB Hires Former NFL Veteran Steven Israel to Lead Specialized Athlete Wealth Management Vertical
MSD Morgan withholds core quarterly earnings data leaving investors uncertain of its latest operating performance
ATGL Alpha Tech reports solid quarterly growth driven by rising demand for its AIpowered enterprise solutions
What Applied Mat AMAT does that builds long term value Q1 2026 Profit Exceeds Views
Corpay CPAY Stock Relative Valuation Review Q4 2025 EPS Misses Views
BioRestor BRTX Q4 2025 Earnings Why the Beat Matters
Omega Flex OFLX Stock Analysis Climbs 052 Eyes on 2860 20260518
Coastal Fin CCB Falls 109 Watching 6550 Support 20260519
Astec Industries ASTE Reports Strong Q1 Revenue Amid Record Backlogs in Heavy Equipment Sector
AudioEye Inc AEYE Q1 2026 Earnings Massive EPS Surprise Highlights Profitability Turnaround Despite Tepid Market Reception
Market Outlook Banking and Auto Stocks Lead Modest Gains Nifty Remains RangeBound
Waterdrop WDH Q3 2025 Earnings EPS 006 Beats Estimates
SpaceX Files S1 for IPO A Monumental Step for Private Space Exploration
XTKG Q4 2019 Earnings Significant EPS Miss and Steep Stock Decline
BMNR Q1 2026 Earnings Positive EPS Surprise Amid No Revenue Disclosure
Noodles Company NDLS Q1 2026 Earnings Loss Per Share of 044 as Stock Declines 315
GOTU Q4 2025 Earnings EPS Beats Estimates Stock Declines Amid Ongoing Challenges
GENB Q1 2026 Earnings WiderThanExpected Loss Amid Pipeline Progress
REMAX Holdings RMAX Edges Higher as Housing Market Uncertainty Lingers
RingCentral RNG Rallies 3 as Shares Test Key Technical Resistance
CaliberCos Inc CWD Slides 211 as Stock Approaches Critical Support at 088
NovoCure NVCR Holds Steady With Modest Gains Testing Key Levels